View Article

Abstract

Background: In Ayurveda, medicated oils are primarily employed to address ailments related to Vata Dosha imbalance. Dasmula Taila, a classical formulation mentioned in Bhaisajya Ratnavali, is used for managing Shiro-roga (head diseases) and nasya (administration of medicament through nostrils). Objectives: Methods: The key ingredients include roots of Bilva (Aegle marmelos (L.) Corrêa), Shyonaka (Oroxylum indicum (L.) Kurz), Gambhari (Gmelina arborea Roxb), Patala (Stereospermum suaveolens (Roxb.) DC), Agnimantha (Clerodendrum phlomidis Linn), Shalaparni (Desmodium gangeticum (L.) DC), Prishniparni (Uraria picta (Jacq.) Desv), Kantakari (Solanum xanthocarpum Schrad. & H. Wend), Brihati (Solanum indicum Linn), Goksura (Tribulus terrestris L.) and murchit Tila Taila. Rich in Tridosha-calming substances, it is prepared by using the traditional Taila-paka method, a form of oil preparation detailed in ancient Ayurvedic texts, and adheres to the prescribed procedures outlined in the Ayurvedic Pharmacopoeia of India (API). The organoleptic study and physicochemical analysis have provided valuable information towards the development of quality control data of the formulation. Also the chemical standards of the formulation were developed using sophisticated analytical techniques like high performance thin layer chromatography (HPTLC) study. Results: As no detail study on the quality control parameters of Dasmula Taila is available in existing literature, this study is essential to establish quality control benchmarks for the prepared Dasmula Taila formulation. In this regard Quality control data of three batches of Dasmula Taila was prepared along with HPTLC profiling. Accelerated shelf life study was also carried out to access its stability and the data suggests that the formulation is stable for at least for 6 months. Conclusion: The current research findings establish the quality control benchmarks for the raw materials used, which will contribute to developing the quality criteria for the Dasmula Taila formulation. This also includes creating an HPTLC fingerprint profile for the Dasmula Taila formulation. Besides this, stability studies of Taila have also been performed.

Keywords

Dasmula Taila, HPTLC, Quality control data, Shelf-life study..

Introduction

Ayurveda is a science of life and it is the ancient and comprehensive medical system, focuses on holistic healing using natural remedies, including herbal formulations and purification procedures [1]. In Ayurveda, Dash stands for ten (10) and Moola stands for Root. Dasmula, a combination of Brihat Panchamoola and Laghu Panchamoola, contains ten roots of ten different plants in equal ratio. Out of the ten roots five roots are of trees, known as Brihat Panchmoola and five roots are of shrubs, known as Laghu panchmoola. Brihat Panchmoola contains Bilva (Aegle marmelos (L.) Corrêa), Shyonaka (Oroxylum indicum (L.) Kurz), Gambhari (Gmelina arborea Roxb), Patala (Stereospermum suaveolens (Roxb.) DC) and Agnimantha (Clerodendrum phlomidis Linn) whereas Laghu Panchmoola contains Shalaparni (Desmodium gangeticum (L.) DC), Prishniparni (Uraria picta (Jacq.) Desv), Kantakari (Solanum xanthocarpum Schrad. & H. Wend), Brihati (Solanum indicum Linn) and Goksura (Tribulus terrestris L.) [2].  Ayurveda makes extensive use of a mixture of these ten (10) roots, which work on Vata and Dosha to lessen their aggravation. There are a plethora of health benefits associated with Dasmula, gout, Parkinson's disease, arthritis, asthma, headaches, puerperal disorders, muscle spasms, lower back aches are the some of those. It has strong analgesic, antioxidant, and anti-inflammatory effects [3-4]. In the Ayurvedic system, health is defined by the equilibrium of Dosha, Dhatu, and Malas, which are the body's regulatory, structural, and waste-removal components [4]. The polyherbal combination is one of the most often used ingredients in Ayurveda medicine, where it is utilized to make various kinds of medicine that are used to treat different disorders. Dasmula Taila is a herbal oil blend prescribed for Nasya treatment in cases of Shiro-roga, a category of head-related ailments [2-3]. Sharma et al. recently conducted a clinical study on the Dasmula Taila Nasya and Shirodhara in Vatika Shiroroga (Tension Headache) [5] which showed that both therapies were approximately equally beneficial, but patients who were administered  Shirodhara with Dashmoola Taila showed better results in comaparison to those administered Nasya Karma with Dasmula Taila. This preparation is also linked to treating Ardhavbhedaka, which is comparable to migraines. The Taila formulation is crafted to harmonize the body’s elements, specifically to soothe Vatadosha without worsening Kapha [6]. During its preparation, known as Snehpaka, Taila uniquely integrates the qualities of the herbs infused into it while retaining its inherent characteristics [7]. This study chooses Dasmula Taila for managing Ardhavbhedaka due to its predominantly Tridoshamaka contents.

MATERIALS AND METHODS

Plant Materials

In the present study, roots of the ten (10) selected plants  roots viz. Bilva (Aegle marmelos (L.) Corrêa), Shyonaka (Oroxylum indicum (L.) Kurz), Gambhari (Gmelina arborea Roxb), Patala (Stereospermum suaveolens (Roxb.) DC), Agnimantha (Clerodendrum phlomidis Linn), Shalaparni (Desmodium gangeticum (L.) DC), Prishniparni (Uraria picta (Jacq.) Desv), Kantakari (Solanum xanthocarpum Schrad. & H. Wend), Brihati (Solanum indicum Linn), Goksura (Tribulus terrestris L.) was collected [2]. The selected plant roots were authenticated by the Pharmacognosy department of CARI, Kolkata, along with macroscopical and powder microscopical characterization as per API. [8-9]

Preparation of Dasmula Taila

 The oil 'Dasmula Taila' was prepared by the roots of ten (10) plants along with Tila taila (sesame oil), which was chemically standardized by testing of the parameters, i.e. Acid value, Saponification value, Unsaponifiable matter, Iodine value, Peroxide value etc. The physicochemical parameters (Loss on drying, Total ash, Acid insoluble ash, water soluble extractive, alcohol soluble extractive, pH, HPTLC) and safety parameters (Heavy metals, microbial load, specific pathogens, pesticide residue testing) analysis were carried out for all the mentioned raw drugs as per API (Table 1). The murchit tila taila was obtained by following the murchana process of Tila taila using the raw drugs viz. Manjistha (Root), Musta (Rz.), Tvak/Nalika (St. Bk.), Haritaki (Fr.), Haridra (Rz), Ketaki (Root), Bibhitaka (Fr.), Amalaki (Fr.), Hrivera (Root), Vatankura (St. Bk.) and Lodhra (St. Bk.) which were macroscopically studied and chemically standardized as per API [10, 11]. At first, all the plant roots were cleaned, washed, dried and powdered separately. After that, all powdered raw drugs were passed individually through a sieve size 80. After that, all these raw drugs, 320 gm each, were taken, and 16 litres of water was added to make a homogeneous mixture. The process began by adding 1 litre Murchit Tila Taila to the mixture and heating it at a temperature range of 50-60 °C for three hours. The heat was turned off once the three hours had elapsed, and the boiler was left to rest overnight. The next day, heating resumed, and froth development was monitored while regularly checking the kalka for varti formation until the froth eventually settled. Subsequently, the varti was strained while still hot (around 80 °C) through a muslin cloth. After cooling, the clear liquid collected was the final Dasmula Taila product.

Physicochemical ananlysis

The powder form of each plant part were used for the physicochemical analysis as per the WHO/API guidelines. For determining the water and alcohol extractive values, the crude powder (4 g) was soaked in the respective solvents (100 mL) with occasional shaking for up to 6 h, followed by keeping the mixture overnight (18 h) at room temperature. The extracts were subsequently concentrated in a hot water bath to obtain constant weights, and the extractive values were calculated. In order to determine Loss on drying, the crude powder (4 g) was kept in hot air oven at 105 °C for 6 h, followed by cooling weight is noted and LOD at 105 °C was calculated. For total ash determination, 2 g of each raw drugs (powder form) were taken in a silica crucibe and incinerated at 450 °C for 6 h. On the next day the weight of the crucible is noted and result is calculated. Now the ash is ready for determination of acid insoluble ash. The ash obtained on the previous day was treated with 25 mL 2(N) HCl and warmed in a water bath, filtered through a ashless filter paper. Once all the liquid were drained, the ashless filter paper was transferred in the same silica crucible and incinerated at 450 °C for 6 h. On the next day the weight of the crucible is noted and result is calculated. In order to check the pH, 10 % aqueous suspension was prepared, kept for 24 h and pH was noted. The formulation Damula Taila is liquid and three (03) batches of formulations have been prepared. Physicochemical investigations viz. determination of Refractive index at 40 °C,  Viscosity, Specific optical rotation, Acid value, Iodine value, Saponification value, Unsaponifiable matter, Peroxide value, Specific gravity and Wt per ml (at 25 °C) of the three batches of Dasmula Taila were carried out following API methods. [12-13]

High Performance Thin Layer Chromatography (HPTLC) study [14-15]

Equipment

A CAMAG HPTLC system (Switzerland), comprising of a CAMAG ATS 4, CAMAG TLC scanner 3, CAMAG Wincats Software, Version 1.44, a CAMAG TLC plate heater, and a CAMAG Visualizer, was used for the study.

Preparation of samples

  1. Murchit Tila Taila (oil) along with raw drugs used for Murchana

For each sample, 1 gram was refluxed with 20 ml of Methanol for one hour. The resulting extracts were then passed through filter paper. The filtrates obtained were concentrated for Thin Layer Chromatography (TLC) analysis.

  1. Dasmula Taila along with its ten (10) raw ingredients and markers

The High-Performance Thin Layer Chromatography (HPTLC) analysis of the Dasmula Taila formulation and the raw materials and reference markers was conducted across three separate batches. Each sample, weighing 1 gram (or 2 mL for Taila), underwent reflux with 20 mL of Methanol for one hour; post-reflux, the solution was filtered through filter paper. The resulting filtrate was then reduced in volume and prepared for TLC analysis. Reference standards were created by dissolving 1 mg each of marmelosin, beta-sitosterol, and lupeol acetate in 10 mL of Methanol.

Stationary phase

Pre-activated 20 × 10 cm aluminum-supported precoated silica gel 60 F254 plates (Merck, India, Batch No. 1.05554.0007) were used.

Application of samples

A 5 µL sample was applied to the plate as an 8 mm band, positioned 15 mm above the plate's base using CAMAG ATS4 applicator.

Mobile phase

  1. Murchit Tila Taila (oil) along with raw drugs used for Murchana

The solvent system used was a mixture of Toluene, Ethyl acetate, and Formic acid in the ratio of 7:3:0.1(v/v).

  1. Dasmula Taila along with its ten (10) raw ingredients and markers

The solvent system comprised a blend of toluene, ethyl acetate, and formic acid in a 7.5:2.5:0.4 (v/v) ratio.

Plate development and detection of spots

The plates were developed to a distance of 90 mm in a CAMAG Twin trough chamber, with a pre-conditioning period of 20 minutes at 25°C and 42% average relative humidity. 20% aqueous sulphuric acid solution was used as the derivatising agent. The TLC plate was developed up to 90 mm in a pre-saturated CAMAG twin trough chamber after preconditioning the plate at 25 °C and relative average humidity of 42%. Images of the developed plate were captured at 254, 366 nm and in white light.

Shelf life study [16-17]

The stability of the formulation was evaluated in a stability chamber (Model: REMI 12C) under regulated conditions (temperature at 38 °C and relative humidity at 75%) over a period of six months, with assessments at intervals of one month (01), three months (03), and six months (06). The stability profile, composed of specific parameters, is essential for determining appropriate storage conditions and the expiration period for pharmaceuticals. The construction of the stability study should rely on an understanding of the drug's characteristics and the physical form in which it is administered. The purpose of the present study was to establish stability data by taking three batches of drug formulation at specified intervals of 0 days, 1st month, 3rd month, and 6th month. Various physical parameters, like the refractive index, viscosity, and specific gravity, as well as chemical parameters, like saponification, acid, and iodine values, were studied.

RESULT AND DISCUSSION

Organoleptic and quality control studies carried out on the ingredients of Dasmula Taila

In Dasmula Taila the ingredients present are the roots of the following ten (10)  plants viz. Bilva (Aegle marmelos (L.) Corrêa), Shyonaka (Oroxylum indicum (L.) Kurz), Gambhari (Gmelina arborea Roxb), Patala (Stereospermum suaveolens (Roxb.) DC), Agnimantha (Clerodendrum phlomidis Linn), Shalaparni (Desmodium gangeticum (L.) DC), Prishniparni (Uraria picta (Jacq.) Desv), Kantakari (Solanum xanthocarpum Schrad. & H. Wend), Brihati (Solanum indicum Linn), Goksura (Tribulus terrestris L.) and Murchit Tila Taila. In The following table (Table 1) photographs, organoleptic findings, physicochemical parametrs and safety parameters of the ingredients of Dasmula Taila are documented.


Table 1: List of ingredients of Dasmula Taila along with their photographs and quality control data

 

Sl. No.

 

Plant Name

Plant part used

 

Photograph

Organoleptic study

Physicochemical Parameters (% w/w)

Safety Parameters

Sl. No.

 

Plant Name

Plant part used

 

 

 

 

Colour

Texture

Odour

 

 

 

1

Bilva [Aegle marmelos

(L.) Corrêa] [18]

(API, Part-I, Vol- III, Pg. 29-31)

Root

 

 

Greyish brown

Rough

Faintly aromatic

1

Bilva [Aegle marmelos

(L.) Corrêa] [18]

(API, Part-I, Vol- III, Pg. 29-31)

Root

2

Shyonaka [Oroxylum

indicum (L.) Kurz] [19]

(API, Part-I, Vol- III, Pg. 209-210)

Root

 

 

Light brown

Rough

Characteristic

2

Shyonaka [Oroxylum

indicum (L.) Kurz] [19]

(API, Part-I, Vol- III, Pg. 209-210)

Root

3

Gambhari [Gmelina

arborea Roxb] [20]

(API, Part-I, Vol- I, Pg. 36-37)

Root

 

 

Orangish brown

Rough

Not characteristic

3

Gambhari [Gmelina

arborea Roxb] [20]

(API, Part-I, Vol- I, Pg. 36-37)

Root

4

Patala [Stereospermum

suaveolens (Roxb.) DC] [21]

(API, Part-I, Vol- III, Pg. 147-148)

Root

 

 

Orangish brown

Rough

No odour

4

Patala [Stereospermum

suaveolens (Roxb.) DC] [21]

(API, Part-I, Vol- III, Pg. 147-148)

Root

5

Agnimantha [Clerodendrum

phlomidis Linn] [22]

(API, Part-I, Vol- III, Pg. 3-4)

Root

 

 

Buff

Rough

Faintly aromatic

5

Agnimantha [Clerodendrum

phlomidis Linn] [22]

(API, Part-I, Vol- III, Pg. 3-4)

Root

6

Shalaparni [Desmodium gangeticum

(L.) DC] [23]

(API, Part-I, Vol- III, Pg. 178-180)

Root

 

 

Brown

Rough

Not characteristic

6

Shalaparni [Desmodium gangeticum

(L.) DC] [23]

(API, Part-I, Vol- III, Pg. 178-180)

Root

7

Prishniparni [Uraria picta

(Jacq.) Desv]

(Not in API)

Root

 

 

Orangish brown

Rough

Not characteristic

7

Prishniparni [Uraria picta

(Jacq.) Desv]

(Not in API)

Root

8

Kantakari [Solanum xanthocarpum Schrad. & H. Wendl]

(Not in API)

Root

 

 

Yellowish brown

Rough

Nil

8

Kantakari [Solanum xanthocarpum Schrad. & H. Wendl]

(Not in API)

Root

9

Brihati [Solanum indicum Linn] [24]

(API, Part-I, Vol- II, Pg. 27-28)

Root

 

 

Greenish brown

Rough

Faint

9

Brihati [Solanum indicum Linn] [24]

(API, Part-I, Vol- II, Pg. 27-28)

Root

10

Goksura [Tribulus terrestris L.] [25]

(API, Part-I, Vol- I, Pg. 40)

Root

 

 

Greenish brown

Rough

Slightly aromatic

10

Goksura [Tribulus terrestris L.] [25]

(API, Part-I, Vol- I, Pg. 40)

Root

11

Tila Taila  (Sesamum oil)

Oil

 

 

Colorless

Oily

Odorless

11

Tila Taila  (Sesamum oil)

Oil

12

Murchit Tila Taila

Oil

 

 

Light brown

Oily

Mild, characteristic

12

Murchit Tila Taila

Oil


Abbreviations: LOD- Loss on drying; TAV: Total ash value; AIA: Acid insoluble ash; WSE- Water soluble extractive; ASE- Alcohol soluble extractive

HPTLC study of Murchit Tila Taila (oil) along with raw drugs used for Murchana

The murchit tila taila was obtained by following the murchana process of Tila taila using the raw drugs viz. Manjistha (Root), Musta (Rz.), Tvak/Nalika (St. Bk.), Haritaki (Fr.), Haridra (Rz), Ketaki (Root), Bibhitaka (Fr.), Amalaki (Fr.), Hrivera (Root), Vatankura (St. Bk.) and Lodhra (St. Bk.). For each sample, 1 gram was refluxed with 20 ml of Methanol for one hour. The resulting extracts were then passed through filter paper. The filtrates obtained were concentrated for Thin Layer Chromatography (TLC) analysis. The TLC was performed on pre-coated Silica Gel Plates (60 F254) supported on aluminium sheets from Merck. The solvent system used was a mixture of Toluene, Ethyl acetate, and Formic acid in the ratio of 7:3:0.1(v/v). A 5 µL sample was applied to the plate as an 8 mm band, positioned 15 mm above the plate's base. The plates, measuring 20x10cm, were developed to a length of 90 mm in a CAMAG Twin trough chamber, with preconditioning at 25 °C and 42% relative humidity. Figure 1 documents the TLC plates scanned at 254 nm and 366 nm while Table 2 lists the Rf valus.

       
            Figure 1.png
       

1    2    3    4     5     6    7     8    9    10   11  12    1    2    3    4     5     6    7     8    9    10   11  12

Figure 1. Photography of Developed HPTLC Plate in (a) 254 nm and (b) 366 nm


Table 2: Rf values

 

Track No.

Sample name

Rf   values

(Observed at 254nm)

Rf    values

(Observed at 366nm)

 

1.

Manjistha (Rt.)

0.04,0.12,0.18,0.61,0.67

0.07,0.12,0.19,0.31,0.36, 0.65,0.73,0.78,0.83

2.

Ketaki (Rt.)

0.04,0.09,0.25,0.32,0.46,0.73

0.06,0.11,0.17,0.21,0.27, 0.73

3.

Haridra (Rz.)

0.05,0.09,0.19,0.24,0.28,0.32,0.40,0.44,00.64,0.75,0.82

0.10,0.20,0.25,0.31,0.39, 0.45,0.55,0.65

 

4.

Lodhra (St. Bk.)

0.14,0.29,0.43

0.18,0.25,0.33,0.39,0.44

5.

Musta (Rz.)

0.12,0.41,0.46

0.32,0.41.

6.

Haritaki (Fr.)

0.04,0.16

0.32, 0.40

7.

Bibhitaki (Fr.)

0.05,0.16,0.32

0.27,0.33,0.40

8.

Tvak (St. Bk.)

0.04,0.51,0.65,0.73

0.41,0.45

9.

Hrivera (Rt.)

0.03,0.33,0.44,0.79

0.41,0.45

10.

Vatnkura (St. Bk.)

0.04,0.44,0.76,0.80

0.18,0.28,0.40,0.46,0.53,0.73,0.83

11.

Amlaki (Fr.)

0.04,0.15

0.32

12.

Murchit Tila Taila

0.04,0.12, 0.61,0.80

0.29,0.40,0.45,0.61,0.71,0.82


Organoleptic studies of Dasmula Taila (oil)

The Dasmula Taila formulation was prepared by the Pharmacy department of CARI, Kolkata, in three batches (Batch-I, II & III). Organoleptic characteristics, macroscopical analysis and photographs of three batches of Dasmula Taila are listed in Table 3.


Table 3: Organoleptic characteristics and photographs of three batches of Dasmula Taila

 

Batch

Organoleptic study

 

Photograph

Colour

Texture

Odour

Taste

I

Brown

Oily

Mild, characteristic

Tasteless

 

 

II

Brown

Oily

Mild, characteristic

Tasteless

 

 

III

Brown

Oily

Mild, characteristic

Tasteless

 

 


Chemical Standardization of Dasmula Taila

The chemical standardization of Dasmula Taila was performed by analysing the following parameters, i.e. determination of Refractive index at 40 °C,  Viscosity, Specific optical rotation, Acid value, Iodine value, Saponification value, Unsaponifiable matter, Peroxide value, Specific gravity and Wt per ml (at 25 °C). Safety parameters i.e. testing of heavy metals, aflatoxins, microbial load, test for specific pathogens and pestiside residue were also carried out. Comparative marker-based HPTLC fingerprinting profile of all ten (10) raw drugs &  three (03) batches of the formulation were also carried out. All these results are documents in Table 4-9.


Table 4:  Physicochemical parameters

 

Parameters

Result (in w/w%)

Limit (As per API)

Batch-I

Batch-II

Batch-III

Refractive index at 40 °C

1.4670

1.4665

1.4670

Not mentioned in API

Viscosity

86.91

82.73

83.51

Specific optical rotation

+0.50

+0.50

+0.50

Acid value

1.37

1.46

1.32

Iodine value

98.67

104.53

100.05

Saponification value

186.76

196.60

191.83

Unsaponifiable matter

1.20

1.22

1.25

Peroxide value

NIL

NIL

NIL

Specific gravity

0.9196

0.9192

0.9198

Wt per ml (at 25 °C)

0.910 g

0.910 g

0.910 g


Table 5: Heavy metals testing:

 

Tests

Protocol

Results (mg/kg)

 

Acceptance Limit (in ppm)

 

 

Batch-I

Batch-II

Batch-III

 

Lead

API

0.39

0.47

0.50

10

Arsenic

API

B.L.Q (0.1)

B.L.Q(0.1)

B.L.Q(0.1)

3.0

Cadmium

API

B.L.Q (0.1)

B.L.Q(0.1)

B.L.Q(0.1)

0.3

Mercury

API

B.L.Q (0.1)

B.L.Q(0.1)

B.L.Q(0.1)

1.0

*1,2,3 Limit of Detection = < 0>

 


Table 6: Aflatoxins:

 

Parameter

Result

 

Permissible Limit as in API (in ppb)

 

Batch-I

Batch-II

Batch-III

 

B1

N.D.

N.D.

N.D.

0.5

B2

N.D.

N.D.

N.D.

0.1

G1

N.D.

N.D.

N.D.

0.5

G2

N.D.

N.D.

N.D.

0.1

 


Table 7: Microbial Load:

 

Tests

Results (in cfu/gm)

Permissible Limit as in API (in cfu/gm)

Batch-I

Batch-II

Batch-III

Total Microbial plate Count

<10>

<10>

<10>

<10>

Yeast and mould count

<10>

<10>

<10>

<10>

 


Table 8: Pathogens testing:

 

Tests

Protocol

Results

Acceptance Limit

Batch-I

Batch-II

Batch-III

Escherichia coli

As per A.P.I

Abs/gm

Abs/gm

Abs/gm

Abs/gm

Salmonella spp.

As per A.P.I

Abs/gm

Abs/gm

Abs/gm

Abs/gm

Staphylococcus aureus

As per A.P.I

Abs/gm

Abs/gm

Abs/gm

Abs/gm

Pseudomonas

As per A.P.I

Abs/gm

Abs/gm

Abs/gm

Abs/gm

*Abs- Absent


Table 9:  Pesticide Residue:

 

Substance (s)

Result $(in ppm)

 

Permissible Limit prescribed in API (in ppm)

 

Batch-I

Batch-II

Batch-III

Batch-I

Alachlor

B.L.Q

B.L.Q

B.L.Q

0.02

Aldrin and Dieldrin (sum of)

B.L.Q

B.L.Q

B.L.Q

0.05

Azinphos-methyl

B.L.Q

B.L.Q

B.L.Q

1.0

Bromopropylate

B.L.Q

B.L.Q

B.L.Q

0.3

Chlordane(sum of cis-,Trans- and Oxythlordane)

B.L.Q

B.L.Q

B.L.Q

0.05

Chlorfenvinphos

B.L.Q

B.L.Q

B.L.Q

0.5

Chlorpyrifos

B.L.Q

B.L.Q

B.L.Q

0.2

Chlorpyrifos-methyl

B.L.Q

B.L.Q

B.L.Q

0.1

Cypermenthrin (and Isomers)

B.L.Q

B.L.Q

B.L.Q

1.0

DDT (sum of p,p-DDT, o,p-DDT, p,p-DDE and p,p-TDE)

B.L.Q

B.L.Q

B.L.Q

1.0

Deltamenthrin

B.L.Q

B.L.Q

B.L.Q

0.5

Diazinon

B.L.Q

B.L.Q

B.L.Q

0.5

Dichlorvos

B.L.Q

B.L.Q

B.L.Q

1.0

Dithiocarbamates (as CS2)

B.L.Q

B.L.Q

B.L.Q

2.0

Endosulfan  (sum of isomers and endosulfan sulphate)

B.L.Q

B.L.Q

B.L.Q

3.0

Endrin

B.L.Q

B.L.Q

B.L.Q

0.05

Ethion

B.L.Q

B.L.Q

B.L.Q

2.0

Fenitrothion

B.L.Q

B.L.Q

B.L.Q

0.5

Fenvalerate

B.L.Q

B.L.Q

B.L.Q

1.5

Fonofos

B.L.Q

B.L.Q

B.L.Q

0.05

Heptachlor (sum of  Heptachlor  and Heptachlorepoxide)

B.L.Q

B.L.Q

B.L.Q

0.05

Hexachlorbenzene

B.L.Q

B.L.Q

B.L.Q

1.0

Hexachlorocyclohexane isomers (other than ?)

B.L.Q

B.L.Q

B.L.Q

0.3

Lindane (?- Hexachlorocyclohexane)

B.L.Q

B.L.Q

B.L.Q

0.6

Malathion

B.L.Q

B.L.Q

B.L.Q

1.0

Methidathion

B.L.Q

B.L.Q

B.L.Q

0.2

Parathion

B.L.Q

B.L.Q

B.L.Q

0.5

Parathion-methyl

B.L.Q

B.L.Q

B.L.Q

0.2

Permethrin

B.L.Q

B.L.Q

B.L.Q

1.0

Phosalone

B.L.Q

B.L.Q

B.L.Q

0.1

Piperonyl Butoxide

B.L.Q

B.L.Q

B.L.Q

3.0

Pirimiphos-methyl

B.L.Q

B.L.Q

B.L.Q

4.0

Pyrethrins (sum of)

B.L.Q

B.L.Q

B.L.Q

3.0

Quintozene (sum of quintozene, pentachloroaniline and methyl pentachlorophnyl sulphide)

B.L.Q

B.L.Q

B.L.Q

1.0


Dasmula Taila along with its ten (10) raw ingredients and markers

The High-Performance Thin Layer Chromatography (HPTLC) analysis of three batches of Dasmula Taila formulation and the raw materials and reference markers was conducted across three separate batches. Each sample, weighing 1 gram (or 2 mL for Taila), underwent reflux with 20 mL of Methanol for one hour; post-reflux, the solution was filtered through filter paper. The resulting filtrate was then reduced in volume and prepared for TLC analysis. Reference standards were created by dissolving 1 mg each of marmelosin, beta-sitosterol, and lupeol acetate in 10 mL of Methanol. For the chromatography, precoated Silica Gel Plates (60 F254) on aluminium sheets supplied by Merck were utilized. The solvent system comprised a blend of toluene, ethyl acetate, and formic acid in a 7.5:2.5:0.4 ratio. The plant extracts, 5 µL each, were applied to the plate as 8 mm bands, placed 15 mm from the bottom edge. The plates, sized 5x10 cm, were developed to a distance of 90 mm in a CAMAG Twin trough chamber, with a preconditioning period of 20 minutes at 25°C and 42% average relative humidity. The chemical development was completed using a 20% aqueous sulphuric acid solution as the derivatising agent.

       
            Figure 2.png
       

Figure 2. Photography of Developed HPTLC Plate in (a) 254 nm, (b) 366 nm and (c) white light


Table 10. Rf values

 

Track No.

Sample name

Rf values (Observed  at 254 nm)

Rf values (Observed at 366 nm)

Rf values (Observed at white light)

1

Dasmula Formulation Batch-I

0.33, 0.47, 0.73

0.04, 0.06, 0.08, 0.15, 0.17, 0.20, 0.24, 0.28, 0.29, 0.32, 0.45, 0.48, 0.58, 0.71

0.47, 0.53, 0.61, 0.75

2

Dasmula Formulation Batch-II

0.32, 0.47, 0.68

0.04, 0.06, 0.08, 0.15, 0.17, 0.20, 0.24, 0.28, 0.29, 0.32, 0.43, 0.47, 0.54, 0.64

0.45, 0.51, 0.57, 0.71

3

Dasmula Formulation Batch-III

0.32, 0.47, 0.68

0.04, 0.06, 0.08, 0.15, 0.17, 0.20, 0.24, 0.28, 0.29, 0.32, 0.43, 0.48, 0.55, 0.65

0.45, 0.51, 0.58, 0.70

4

Shalaparni (Rt.)

0.07

0.15, 0.18, 0.61

0.05, 0.09, 0.13, 0.18, 0.22, 0.24, 0.34, 0.39, 0.45, 0.49, 0.86

5

Agnimantha (Rt.)

0.07, 0.48

0.03, 0.09, 0.24, 0.30, 0.37, 0.60

0.45, 0.60, 0.87

6

Goksura (Rt.)

0.05

0.03, 0.08, 0.09, 0.13, 0.17, 0.21, 0.28, 0.33, 0.38, 0.45, 0.59

0.04, 0.07, 0.47, 0.58, 0.65, 0.77, 0.86

7

Brishniparni (Rt.)

0.02

0.16, 0.18, 0.59

0.04, 0.47, 0.86

8

Bilva (Rt.)

0.08, 0.19, 0.31, 0.44, 0.53, 0.62

0.02, 0.04, 0.09, 0.15, 0.21, 0.25, 0.31, 0.36, 0.39, 0.44, 0.50, 0.55, 0.62

0.07, 0.10, 0.14, 0.23, 0.32, 0.47, 0.59, 0.86

9

Gambhari (Rt.)

0.63

0.08, 0.14, 0.21, 0.29, 0.59

0.47, 0.58, 0.64, 0.79, 0.86

10

Brihati (Rt.)

0.06

0.08, 0.21, 0.25, 0.29, 0.59

0.47

11

Patala (Rt.)

0.08, 0.11, 0.13, 0.15, 0.22, 0.32, 0.36, 0.52, 0.57, 0.64, 0.70

0.03, 0.07, 0.08, 0.12, 0.27, 0.30, 0.37, 0.41, 0.49, 0.59, 0.74, 0.81

0.35, 0.47, 0.55, 0.60, 0.72

12

Shyonaka (Rt.)

0.07, 0.63

0.03, 0.09, 0.16, 0.59, 0.63, 0.73

0.12, 0.47, 0.59, 0.78, 0.85

13

Kantakari (Rt.)

-

0.08, 0.21, 0.25, 0.60

0.47

14

Marmelosin

0.55

0.55

0.55

15

Beta- sitosterol

-

-

0.48

16

Lupeol acetate

-

-

0.59


Shelf life Study of Dasmula Taila

Three batches of Dasmula taila formulation were prepared at Pharmacy department of CARI Kolkata and were kept in stability chamber at the Department of Chemistry for stability assessment and accelerated stability study. Understanding shelf life ensures that the prepared Dasmula Taila maintain acceptable quality and safety standards. Table 11 documents the comparative test result of Dasmula Taila kept in controlled environmental condition at temperature 38 °C and relative (RH) humidity 75% over a period of six months, with assessments at intervals of one month (01), three months (03), and six months (06).


Table 11: Comparative test result of Dasmula Taila kept in controlled environmental condition Temperature 38 °C and Relative (RH) Humidity 75% (Test reports after sample standing in Stability chamber)

 

Sl. No.

Test parameters

Unit

0 day

1st month

3rd month

6th month

B-I

B-II

B-III

B-I

B-II

B-III

B-I

B-II

B-III

B-I

B-II

B-III

 

1

Refractive index at 40 °C

-

1.4670

1.4665

1.4665

1.4691

1.4668

1.4701

1.4720

1.4705

1.4721

1.4735

1.4741

1.4742

 

2

Viscosity

mpa/sec

86.91

82.73

83.51

89.95

87.37

85.25

96.21

91.29

92.61

101.5

95.96

97.82

 

3

Specific optical rotation

 

+0.50

+0.50

+0.50

+0.50

+0.50

+0.50

+0.50

+0.50

+0.50

+0.50

+0.50

+0.50

 

4

Specific gravity

-

0.9196

0.9192

0.9198

0.9199

0.92

0.92

0.9199

0.92

0.9199

0.92

0.92

0.92

 

5

Saponification value

-

186.76

196.60

191.83

196.53

210.55

205.10

203.04

217.86

210.33

207.55

221.56

216.52

 

6

Unsaponifiable matter

-

1.20

1.22

1.25

1.21

1.24

1.26

1.23

1.25

1.28

1.25

1.29

1.30

 

7

Acid value

-

1.37

1.46

1.32

1.66

1.81

1.58

1.81

2.04

1.85

2.63

2.84

2.67

 

8

Iodine value

-

98.67

104.53

100.05

96.74

103.82

98.31

94.93

102.89

96.84

93.82

100.63

94.98

 

9

Peroxide value

-

NIL

NIL

NIL

NIL

NIL

NIL

NIL

NIL

NIL

NIL

NIL

NIL

 

10

Heavy metals

 

Cd

ppm

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

 

 

Pb

ppm

0.39

0.47

0.50

0.39

0.47

0.50

0.39

0.47

0.50

0.39

0.47

0.50

 

 

As

ppm

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

 

 

Hg

ppm

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

 

11

Microbial load

 

Total microbial plate count

cfu/

gm

<10>

<10>

<10>

<10>

<10>

<10>

<10>

<10>

<10>

<10>

<10>

<10>

 

 

Yeast and mould count

cfu/

gm

<10>

<10>

<10>

<10>

<10>

<10>

<10>

<10>

<10>

<10>

<10>

<10>

 

12

Specific pathogens

 

E. coli

/ml

A

A

A

A

A

A

A

A

A

A

A

A

 

 

Salmonella

/ml

A

A

A

A

A

A

A

A

A

A

A

A

 

 

Pseudomonas aeruginosa

/ml

A

A

A

A

A

A

A

A

A

A

A

A

 

 

S. aureus

/ml

A

A

A

A

A

A

A

A

A

A

A

A

 

13

Pesticide residue

-

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

 

14

Aflatoxins

 

B1

ppb

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

 

 

B2

ppb

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

 

 

G1

ppb

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

 

 

G2

ppb

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

 

                                                 

 

The refractive index (RI) serves as an indicator of a sample's purity. It is commonly measured using refractometers in the pharmaceutical industry to ensure the quality of raw, intermediate, and final products. Typically, this measurement is conducted at the sodium D-line (NaD) wavelength of approximately 589 nm589 nm. The recorded values for batches I, II, and III are 1.4670, 1.4665, and 1.4665 respectively, suggesting consistency across the batches with no significant variation. Viscosity is a fluid's resistance to flow or change shape at a specified rate. The values obtained in (Pa-sec) are 86.91, 82.73, 83.51 of batches I, II and III, respectively at 0 day and 101.5, 95.96, 97.82 (Pa-sec) of batches I, II and III at 6 months [Figure 3(a)] thus indicating that a slight increase viscosity of Dasmula Taila upon storage.


       
            Figure 3..png
       

Figure 3. (a): Graph of Viscosity vs No. of days; (b): Graph of Acid value vs No. of days

Specific rotation can also be used to test the purity of the material. The Specific Optical Rotation (SOR) is denoted by [?]. SOR means examining the same at a specific temperature like - is constant at +0.50 for batches in the initial 0th day and at the 6th month. This formulation is stable. It can also be used to test the purity of the material. The specific gravity was measured at 40 °C. The values of batches did not show any significant changes in values of 0 day and 6th month. Thus, the formulation is stable. The saponification values of batches I, II and III at specific intervals of 0 day, 1st, 3rd, and 6th months showed an increase in Figure 3(b). The values were 186.76, 196.60, and 191.83 for batches I, II, and III on the 0th day to 207.55, 221.56 and 216.52 for batches I, II, and III at the end of six months, respectively. A greater saponification value indicates that the fatty acids present are, on average, shorter in chain length. There is no peroxide value, which suggests that the formulation is stable. Unsaponifiable matter is within the specified limit of 1.5, suggesting fit for topical usage. The highest acid value found at the 6th month suggests that prepared Taila could remain stable for up to 6 months, i.e. 180 days. The Iodine value typically reflects the oxidative resilience of fats, which is closely linked to the degree of unsaturation. This factor significantly influences the processing, longevity, and appropriate use of fat based products. The Iodine values of batches I, II and III at specific intervals of 0 day, 1st, 3rd, and 6th months showed a decrease trajectory. The values were 98.67, 104.53 and 100.05 for batches I, II, and III on the 0th day to 93.82, 100.63 and 94.98 for batches I, II, and III at the end of six months, respectively.

High-Performance Thin Layer Chromatography Profile of Dasmula Taila (B-I, II, III)

For the analysis, 2 mL of each Dasmula Taila batch (B-I, II, III) was refluxed with 20 mL of Methanol for one hour. The mixture was filtered through filter paper, and the filtrate was reduced in volume for Thin Layer Chromatography (TLC). A TLC Silica Gel 60F254 plate, supported on aluminium sheets, served as the stationary phase. The solvent mixture used was Toluene, Ethyl acetate, and Formic acid in a 7.5:2.5:0.4 (v/v) ratio. A 5 µL sample was applied as an 8 mm band, 15 mm from the plate's bottom. The plate, measuring 5x10 cm, was developed to 90 mm in a CAMAG Twin trough chamber under conditions of 25 °C and 42% humidity. Finally, 20% aqueous sulphuric acid was employed as the derivatising agent. Table 12 documents the comparative test result of HPTLC of Dasmula Taila kept in controlled environmental condition at temperature 38 °C and relative (RH) humidity 75% over a period of six months, with assessments at intervals of one month (01), three months (03), and six months (06).


Table 12: Rf values

 

Time

Photographs

254 nm

366 nm

White light

 

 

1st month

Temperature 38 °C

and Relative (RH)

Humidity 75%

 

 

 

 

 

 

 

I    II   III

 

 

 

 

 

 

 

I     II   III

 

 

 

 

 

 

 

I     II   III

 

 

 

 

Rf values

Batch-I

0.33, 0.47, 0.73

0.04, 0.06, 0.08, 0.15, 0.17, 0.20, 0.24, 0.28, 0.29, 0.32, 0.45, 0.48, 0.58, 0.71

0.47, 0.53, 0.61, 0.74

Batch-II

0.32, 0.47, 0.73

0.04, 0.06, 0.08, 0.15, 0.17, 0.20, 0.24, 0.28, 0.29, 0.32, 0.43, 0.47, 0.54, 0.64

0.45, 0.51, 0.57, 0.74

Batch-III

0.32, 0.47, 0.74

0.04, 0.06, 0.08, 0.15, 0.17, 0.20, 0.24, 0.28, 0.29, 0.32, 0.43, 0.48, 0.55, 0.65

0.45, 0.51, 0.58, 0.75

 

 

3rd month

Temperature 38 °C

and Relative (RH)

Humidity 75%

 

 

 

 

 

 

 

I     II    III

 

 

 

 

 

 

 

I      II    III

 

 

 

 

 

 

 

I      II    III

 

 

 

 

Rf values

Batch-I

0.33, 0.47, 0.73

0.04, 0.06, 0.08, 0.15, 0.17, 0.20, 0.24, 0.28, 0.29, 0.32, 0.45, 0.48, 0.58, 0.71

0.47, 0.53, 0.61, 0.74

Batch-II

0.32, 0.47, 0.73

0.04, 0.06, 0.08, 0.15, 0.17, 0.20, 0.24, 0.28, 0.29, 0.32, 0.43, 0.47, 0.54, 0.64

0.45, 0.51, 0.57, 0.74

Batch-III

0.32, 0.47, 0.74

0.04, 0.06, 0.08, 0.15, 0.17, 0.20, 0.24, 0.28, 0.29, 0.32, 0.43, 0.48, 0.55, 0.65

0.45, 0.51, 0.58, 0.75

 

 

6th month

Temperature 38 °C

and Relative (RH)

Humidity 75%

 

 

 

 

 

 

 

 

I    II   III

 

 

 

 

 

 

 

 

I    II   III

 

 

 

 

 

 

 

 

I    II   III

 

 

 

 

Rf values

Batch-I

0.33, 0.47, 0.73

0.04, 0.06, 0.08, 0.15, 0.17, 0.20, 0.24, 0.28, 0.29, 0.32, 0.45, 0.48, 0.58, 0.71

0.47, 0.53, 0.61, 0.74

Batch-II

0.32, 0.47, 0.73

0.04, 0.06, 0.08, 0.15, 0.17, 0.20, 0.24, 0.28, 0.29, 0.32, 0.43, 0.47, 0.54, 0.64

0.45, 0.51, 0.57, 0.74

Batch-III

0.32, 0.47, 0.74

0.04, 0.06, 0.08, 0.15, 0.17, 0.20, 0.24, 0.28, 0.29, 0.32, 0.43, 0.48, 0.55, 0.65

0.45, 0.51, 0.58, 0.75


CONCLUSION

The findings of quality control parameters of Dasmula Taila i.e., refractive index (at 40 °C), specific gravity, acid value, iodine value, saponification value and unsaponifiable matter is incorporated in this study to establish the quality control benchmarks for the raw drug materials used, which will contribute to the development of the quality standards for the Dasmula Taila formulation. High-performance thin Layer Chromatography fingerprint profiling of Dasmula Taila formulation and its ingredients comply with the various reference standards. Accelerated shelf-life study of Dasmula Taila have been performed and reported first time. As no standard reference is available for this formulation, the present quality assessment report may be helpful for the preparation of the monograph and quality control data may be used as references which will setting the pharmacopeial standards for Dasmula Taila formulation. It may also help to assess the quality of this formulation for research and clinical purposes in future.

Financial support and sponsorship

Financial support from CCRAS Hqrs. is gratefully acknowledged.

Conflicts of interest

There are no conflicts of interest.

Data availability statement

This article includes all data generated or analyzed during this study.

ACKNOWLEDGEMENT

We are very much thankful to the Director-General, CCRAS for sanctioning the Project (F. No. 3-31/2020-CCRAS/Admn/IMR/8025 dt. 12.03.2020) entitled “Development of Quality Standards and SOP for the Dasmula Taila Formulation” and for providing the necessary facilities at the Central Ayurveda Research Institute, Kolkata to carry out the research work.

REFERENCES

  1. Jaiswal YS, Williams LL. A glimpse of Ayurveda - The forgotten history and principles of Indian traditional medicine. J Tradit Complement Med. 2016 Feb 28;7(1):50-53. https://doi/org10.1016/j.jtcme.2016.02.002
  2. Bheshaajya Ratnavali – Shri Govind Das Virachita, Vyakhyaakar Kaviraj Sri Ambika dutta Shastri Ayurvedacharya, Chaukhambha Prakaashana, Varanasi, sanvata 2073, 5/1406 Shiroroga Chikitsa Prakaran 65/111-112
  3. Poonam Taru, Sabeena Hussain Syed et al. Dashamoola: A systemetic overview. 2022, GIS-Zeitschrift fü Geoinformatik 9(4):1334-1345.
  4. Kaviraj Dr. Ambika Dutt Shastri.Shushruta Samhita Ayurveda tatwa sandeepika part 1 Chaukhamba Sankrit Sansthan Varanasi Ardhavbhedaka, Sutra.sthan-.25/15.
  5. Sharma S.A Comparative Study of Dashmoola Taila Nasya and Shirodhara in Vatika Shiroroga (Tension Headache). Journal of Natural & Ayurvedic Medicine, 2024, 8(1):1-10.
  6. Kaviraj Dr. Ambika Dutt Shastri.Shushruta Samhita Ayurveda tatwa sandeepika part 1 Chaukhamba Sankrit Sansthan Varanasi, sutrasthan 15/48.
  7. Pt. Kashinath Shastri and Dr. Gorakhnath Chaturvedi Charak Samhita Vidhyotini Hindivyakhya Pratham bhag Chaukhamba Bharti Akadami, Varanasi, sutra sthan 13/15.
  8. Anonymous. Quality Control Methods for Herbal Materials. Geneva, Switzerland: World Health Organization; 2011. p. 45-7.
  9. Anonymous. Ayurvedic Pharmacopoeia of India. Vol. 1. New Delhi, India: Min. of Health & Family Welfare, Govt. of India; 1992. p. 142-3.
  10. Akshata S, Gowda S, Doddamani M. A conceptual review on Taila murchana. IJRAPS, 2018; 1(1):82-85.
  11. https://www.easyayurveda.com/2017/08/21/murchita-tila-taila-murchana/
  12. Anonymous. Quality Control Methods for Herbal Materials. 1st ed. Vol. 1. Geneva: World Health Organization; 2011. p. 45-7.
  13. Anonymous. The Ayurvedic Pharmacopoeia of India. Part-I, Vol. I. New Delhi, India: Min. of Health & Family Welfare, Govt. of India, Department of AYUSH; 2004. p. 159-160.
  14. Stahl E. Thin Layer Chromatography, A Laboratory Handbook. 2nd ed., New Delhi: Springer (I) Pvt. Ltd.; 2005. p. 768.
  15. Reich E, Schibili A. High Performance Thin Layer Chromatography, 1st ed., Vol. 1. New York: Thieme Publication; 2006. p. 145.
  16. Lachman, Leon and H.A. Lieberman, The theory and practices of industrial pharmacy, 3rd edition, Varghese publishing Co.
  17. Gilberts S. Banker and C.T. Rhodes, Modern Pharmaceutics Marcel Decker.
  18. Anonymous. The Ayurvedic Pharmacopoeia of India. Part-I, Vol. III. New Delhi, India: Min. of Health & Family Welfare, Govt. of India, Department of ISM & H; 2001. p. 29-31.
  19. Anonymous. The Ayurvedic Pharmacopoeia of India. Part-I, Vol. III. New Delhi, India: Min. of Health & Family Welfare, Govt. of India, Department of ISM & H; 2001. p. 209-210.
  20. Anonymous. The Ayurvedic Pharmacopoeia of India. Part-I, Vol. I. New Delhi, India: Min. of Health & Family Welfare, Govt. of India, Department of ISM & H; 2001. p. 36-37.
  21. Anonymous. The Ayurvedic Pharmacopoeia of India. Part-I, Vol. III. New Delhi, India: Min. of Health & Family Welfare, Govt. of India, Department of ISM & H; 2001. p. 147-148.
  22. Anonymous. The Ayurvedic Pharmacopoeia of India. Part-I, Vol. III. New Delhi, India: Min. of Health & Family Welfare, Govt. of India, Department of ISM & H; 2001. p. 3-4.
  23. Anonymous. The Ayurvedic Pharmacopoeia of India. Part-I, Vol. III. New Delhi, India: Min. of Health & Family Welfare, Govt. of India, Department of ISM & H; 2001. p. 178-180.
  24. Anonymous. The Ayurvedic Pharmacopoeia of India. Part-I, Vol. II. New Delhi, India: Min. of Health & Family Welfare, Govt. of India, Department of ISM & H; 1999. p. 27-28.
  25. Anonymous. The Ayurvedic Pharmacopoeia of India. Part-I, Vol. I. New Delhi, India: Min. of Health & Family Welfare, Govt. of India, Department of ISM & H; 2001. p. 38-39..

Reference

  1. Jaiswal YS, Williams LL. A glimpse of Ayurveda - The forgotten history and principles of Indian traditional medicine. J Tradit Complement Med. 2016 Feb 28;7(1):50-53. https://doi/org10.1016/j.jtcme.2016.02.002
  2. Bheshaajya Ratnavali – Shri Govind Das Virachita, Vyakhyaakar Kaviraj Sri Ambika dutta Shastri Ayurvedacharya, Chaukhambha Prakaashana, Varanasi, sanvata 2073, 5/1406 Shiroroga Chikitsa Prakaran 65/111-112
  3. Poonam Taru, Sabeena Hussain Syed et al. Dashamoola: A systemetic overview. 2022, GIS-Zeitschrift fü Geoinformatik 9(4):1334-1345.
  4. Kaviraj Dr. Ambika Dutt Shastri.Shushruta Samhita Ayurveda tatwa sandeepika part 1 Chaukhamba Sankrit Sansthan Varanasi Ardhavbhedaka, Sutra.sthan-.25/15.
  5. Sharma S.A Comparative Study of Dashmoola Taila Nasya and Shirodhara in Vatika Shiroroga (Tension Headache). Journal of Natural & Ayurvedic Medicine, 2024, 8(1):1-10.
  6. Kaviraj Dr. Ambika Dutt Shastri.Shushruta Samhita Ayurveda tatwa sandeepika part 1 Chaukhamba Sankrit Sansthan Varanasi, sutrasthan 15/48.
  7. Pt. Kashinath Shastri and Dr. Gorakhnath Chaturvedi Charak Samhita Vidhyotini Hindivyakhya Pratham bhag Chaukhamba Bharti Akadami, Varanasi, sutra sthan 13/15.
  8. Anonymous. Quality Control Methods for Herbal Materials. Geneva, Switzerland: World Health Organization; 2011. p. 45-7.
  9. Anonymous. Ayurvedic Pharmacopoeia of India. Vol. 1. New Delhi, India: Min. of Health & Family Welfare, Govt. of India; 1992. p. 142-3.
  10. Akshata S, Gowda S, Doddamani M. A conceptual review on Taila murchana. IJRAPS, 2018; 1(1):82-85.
  11. https://www.easyayurveda.com/2017/08/21/murchita-tila-taila-murchana/
  12. Anonymous. Quality Control Methods for Herbal Materials. 1st ed. Vol. 1. Geneva: World Health Organization; 2011. p. 45-7.
  13. Anonymous. The Ayurvedic Pharmacopoeia of India. Part-I, Vol. I. New Delhi, India: Min. of Health & Family Welfare, Govt. of India, Department of AYUSH; 2004. p. 159-160.
  14. Stahl E. Thin Layer Chromatography, A Laboratory Handbook. 2nd ed., New Delhi: Springer (I) Pvt. Ltd.; 2005. p. 768.
  15. Reich E, Schibili A. High Performance Thin Layer Chromatography, 1st ed., Vol. 1. New York: Thieme Publication; 2006. p. 145.
  16. Lachman, Leon and H.A. Lieberman, The theory and practices of industrial pharmacy, 3rd edition, Varghese publishing Co.
  17. Gilberts S. Banker and C.T. Rhodes, Modern Pharmaceutics Marcel Decker.
  18. Anonymous. The Ayurvedic Pharmacopoeia of India. Part-I, Vol. III. New Delhi, India: Min. of Health & Family Welfare, Govt. of India, Department of ISM & H; 2001. p. 29-31.
  19. Anonymous. The Ayurvedic Pharmacopoeia of India. Part-I, Vol. III. New Delhi, India: Min. of Health & Family Welfare, Govt. of India, Department of ISM & H; 2001. p. 209-210.
  20. Anonymous. The Ayurvedic Pharmacopoeia of India. Part-I, Vol. I. New Delhi, India: Min. of Health & Family Welfare, Govt. of India, Department of ISM & H; 2001. p. 36-37.
  21. Anonymous. The Ayurvedic Pharmacopoeia of India. Part-I, Vol. III. New Delhi, India: Min. of Health & Family Welfare, Govt. of India, Department of ISM & H; 2001. p. 147-148.
  22. Anonymous. The Ayurvedic Pharmacopoeia of India. Part-I, Vol. III. New Delhi, India: Min. of Health & Family Welfare, Govt. of India, Department of ISM & H; 2001. p. 3-4.
  23. Anonymous. The Ayurvedic Pharmacopoeia of India. Part-I, Vol. III. New Delhi, India: Min. of Health & Family Welfare, Govt. of India, Department of ISM & H; 2001. p. 178-180.
  24. Anonymous. The Ayurvedic Pharmacopoeia of India. Part-I, Vol. II. New Delhi, India: Min. of Health & Family Welfare, Govt. of India, Department of ISM & H; 1999. p. 27-28.
  25. Anonymous. The Ayurvedic Pharmacopoeia of India. Part-I, Vol. I. New Delhi, India: Min. of Health & Family Welfare, Govt. of India, Department of ISM & H; 2001. p. 38-39..

Photo
Manosi Das
Corresponding author

Central Ayurveda Research Institute, CCRAS, Ministry of Ayush, 4-CN Block, Bidhannagar, Sector- V, Kolkata- 700091.

Photo
Sudipto Debnath
Co-author

Central Ayurveda Research Institute, CCRAS, Ministry of Ayush, 4-CN Block, Bidhannagar, Sector- V, Kolkata- 700091.

Photo
Rajesh Bolleddu
Co-author

Central Ayurveda Research Institute, CCRAS, Ministry of Ayush, 4-CN Block, Bidhannagar, Sector- V, Kolkata- 700091.

Photo
Susmita Mondal
Co-author

Central Ayurveda Research Institute, CCRAS, Ministry of Ayush, 4-CN Block, Bidhannagar, Sector- V, Kolkata- 700091.

Photo
Parth Gharat
Co-author

Central Ayurveda Research Institute, CCRAS, Ministry of Ayush, 4-CN Block, Bidhannagar, Sector- V, Kolkata- 700091.

Photo
Varanasi Subhose
Co-author

Central Ayurveda Research Institute, CCRAS, Ministry of Ayush, 4-CN Block, Bidhannagar, Sector- V, Kolkata- 700091.

Photo
Ajay Kumar Meena
Co-author

Central Ayurveda Research Institute, CCRAS, Ministry of Ayush, 4-CN Block, Bidhannagar, Sector- V, Kolkata- 700091.

Photo
Ravindra Singh
Co-author

Central Ayurveda Research Institute, CCRAS, Ministry of Ayush, 4-CN Block, Bidhannagar, Sector- V, Kolkata- 700091.

Photo
Gajji Babu
Co-author

Central Ayurveda Research Institute, CCRAS, Ministry of Ayush, 4-CN Block, Bidhannagar, Sector- V, Kolkata- 700091.

Manosi Das*, Sudipto Debnath, Rajesh Bolleddu, Susmita Mondal, Parth Gharat, Varanasi Subhose, Ajay Kumar Meena, Ravindra Singh, Gajji Babu, Quality Control and Shelf-Life Study of Dasmula Taila- A Classical Ayurvedic Formulation for Nasya, Int. J. of Pharm. Sci., 2025, Vol 3, Issue 1, 1871-1888. https://doi.org/10.5281/zenodo.14718352

More related articles
A Review Article on: Drug Discovery and Developmen...
Shruti Shinde , Aaditee Gore, Dr. Megha Salve, ...
Formulation And Evaluation Of Resorcinol Gel With ...
Prerana Sahu, Radha Rani Verma, Dr. Gyanesh Sahu , Dr. Harish Sha...
Abhadya Churna-A Polyherbal Formulation for Grihad...
Dr. Susmita Mondal, Manosi Das, Debajyoti Das, Sreya Dutta, Ajay ...
QbD Based Optimization Of Luliconazole Loaded Transferosomal Gel For Topical Fun...
Urvashi Bharpoda, Dr. SHAH CHAINESH NARENDRABHAI, Patel Mansi Manishchandra, Dr. Umesh M. Upadhyay ,...
Formulation and Evaluation of Kalanchoe Pinnata Syrup: A Pharmaceutical Dosage F...
Ravula Tulasi Naga Pavan Kumar, Boddani Sunil, Pattem Sirsha, Suma Sri Potti, Ayennedi Kusuma Lalith...
A Comprehensive Review On: Barleria Cristata Linn. (Acanthaceae)...
Mrityunjoy Mondal, Poonam Pant, Mahendra Rana, ...
Related Articles
Formulation and Evaluation of Polyherbal Handwash ...
Abhijeet Welankiwar, Vishal Lahane, Shwetlana Shambharkar, Sejal Purohit, Gauri Saraskar, Anushka Pa...
Visionary Nanomedicine: Transforming Ocular Therapy with Nanotechnology-Based Dr...
Anuradha Verma, Anshika Garg, Megha, Manish Singh, Babita Kumar, ...
The Blueprint of Healing: Exploring the Frontiers of Gene Therapy...
Prajwal Aher, Sakshi Waikar, Gauri Salave, Pooja Gangurde, Dr. Atul Bendale, Dr. Anil Jadhav, ...
A Review Article on: Drug Discovery and Development...
Shruti Shinde , Aaditee Gore, Dr. Megha Salve, ...
More related articles
A Review Article on: Drug Discovery and Development...
Shruti Shinde , Aaditee Gore, Dr. Megha Salve, ...
Formulation And Evaluation Of Resorcinol Gel With Rose Extract For eczema...
Prerana Sahu, Radha Rani Verma, Dr. Gyanesh Sahu , Dr. Harish Sharma , ...
Abhadya Churna-A Polyherbal Formulation for Grihadarsi...
Dr. Susmita Mondal, Manosi Das, Debajyoti Das, Sreya Dutta, Ajay K. Meena, Gajji Babu, ...
A Review Article on: Drug Discovery and Development...
Shruti Shinde , Aaditee Gore, Dr. Megha Salve, ...
Formulation And Evaluation Of Resorcinol Gel With Rose Extract For eczema...
Prerana Sahu, Radha Rani Verma, Dr. Gyanesh Sahu , Dr. Harish Sharma , ...
Abhadya Churna-A Polyherbal Formulation for Grihadarsi...
Dr. Susmita Mondal, Manosi Das, Debajyoti Das, Sreya Dutta, Ajay K. Meena, Gajji Babu, ...